NeoPhotonics Corporation (NYSE: NPTN), a leading designer and manufacturer of optoelectronic solutions for the highest speed communications networks in telecom and data center applications, today announced financial results for its fourth quarter and fiscal year ended December 31, 2018.
“NeoPhotonics delivered its highest revenue quarter in the past two years, with strong orders and shipments, non-GAAP profitable operations and positive cash flow,” said Tim Jenks, NeoPhotonics Chairman and CEO. “With continued strength in demand, combined with increasing volume growth across leading high speed product lines, we again achieved solid gross margin expansion,” concluded Mr. Jenks.
Fourth Quarter Summary
- Revenue was $91.1 million, up 11% quarter-over-quarter and 19% year-over-year
- Gross margin was 24.8%, up from 23.2% in the prior quarter
- Non-GAAP Gross margin was 28.6%, up from 24.0% in the prior quarter
- Diluted net loss per share was $0.15, an improvement from a net loss of $0.18 per share in the prior quarter
- Non-GAAP diluted net income per share was $0.05, an improvement from a net loss of $0.05 in the prior quarter
- Cash generated from operations was $10.6 million, down from $13.5 million in the prior quarter
- Adjusted EBITDA was $10.5 million, up from $6.2 million in the prior quarter
Non-GAAP results in the fourth quarter of 2018 exclude $3.6 million of stock-based compensation expense, $0.3 million of amortization of acquisition-related intangibles, $2.6 million for inventory write-downs, $2.2 million for a litigation settlement and $1.3 million of restructuring charges. A reconciliation of the non-GAAP and Adjusted EBITDA financial measures to the most directly comparable GAAP financial measures is provided in the financial schedules portion at the end of this press release.
Annual Summary
- Revenue in 2018 was $322.5 million, compared to $292.9 million in 2017
- Gross margin was 20.5%, compared to 21.0% in 2017
- Non-GAAP Gross margin was 22.3%, compared to 22.5% in 2017
- Diluted net loss per share was $0.97, compared to $1.23 in 2017
- Non-GAAP diluted net loss per share was $0.45, compared to $0.92 in 2017
- Cash generated from operations was $19.6 million, compared to negative $32.8 million in 2017
- Adjusted EBITDA was $14.2 million, compared to negative $10.1 million in 2017
Non-GAAP results in 2018 exclude $14.1 million of stock-based compensation expense, $1.2 million of amortization of acquisition-related intangibles, $3.3 million of restructuring charges, $2.6 million for litigation settlement charges and $2.6 million for inventory write-downs. A reconciliation of the non-GAAP and Adjusted EBITDA financial measures to the most directly comparable GAAP financial measures is provided in the financial schedules portion at the end of this press release.
As of December 31, 2018, cash and cash equivalents, short-term investments and restricted cash, together totaled $76.7 million, up $12.0 million compared to September 30, 2018. Restricted cash as of December 31, 2018 was $11.1 million, up $5.9 million compared to September 30, 2018.
Outlook for the Quarter Ending March 31, 2019
| GAAP | Non-GAAP | |||
| Revenue | $77 to $82 million | |||
| Gross Margin | 20% to 24% | 23% to 27% | ||
| Operating Expenses | $27 to $28 million | $24 to $25 million | ||
| Earnings per share | $(0.28) to $(0.19) net loss | $(0.17) to $(0.08) net loss | ||
The non-GAAP outlook for the first quarter of 2019 excludes the expected impact of stock-based compensation expense of approximately $3.5 million, of which $0.6 million is estimated for cost of goods sold, the impact of expected amortization of intangibles of approximately $0.3 million and restructuring charges of approximately $1.5 million for accelerated depreciation on an end-of-life production line.
Non-GAAP and Adjusted EBITDA Measures vs. GAAP Financial Measures
The Company’s non-GAAP and adjusted EBITDA measures exclude certain GAAP financial measures. A reconciliation of the non-GAAP and Adjusted EBITDA financial measures to the most directly comparable GAAP financial measures is provided in the financial schedules portion at the end of this press release. These non-GAAP financial measures differ from GAAP measures with the same captions and may differ from non-GAAP financial measures with the same or similar captions that are used by other companies. As such, these non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.
The Company uses these non-GAAP financial measures to analyze its operating performance and future prospects, develop internal budgets and financial goals, and to facilitate period-to-period comparisons. NeoPhotonics believes that these non-GAAP financial measures reflect an additional way of viewing aspects of its operations that, when viewed with its GAAP results, provide a more complete understanding of factors and trends affecting its business.
Conference Call
The Company will host a conference call today, Thursday, February 28, 2019 at 4:30 P.M. Eastern Time (1:30 P.M. Pacific Time). The call will be available, live, to interested parties by dialing +1-855-719-5012. For international callers, please dial +1-334-323-0522. The Conference ID number is 5578535. Please dial into the conference call 5-10 minutes prior to the scheduled start time.
A live webcast will be available in the Investor Relations section of NeoPhotonics’ website at: http://ir.neophotonics.com/phoenix.zhtml?c=236218&p=irol-calendar.
A replay of the webcast will be available in the Investor Relations section of the Company’s website approximately two hours after the conclusion of the call and remain available for approximately 30 calendar days.
About NeoPhotonics
NeoPhotonics is a leading designer and manufacturer of optoelectronic solutions for the highest speed communications networks in telecom and datacenter applications. The Company’s products enable cost-effective, high-speed data transmission and efficient allocation of bandwidth over communications networks. NeoPhotonics maintains headquarters in San Jose, California and ISO 9001:2000 certified engineering and manufacturing facilities in Silicon Valley (USA), Japan and China. For additional information visit www.neophotonics.com.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
This press release includes statements that qualify as forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements about the following topics: future financial results, demand for the Company’s high-speed products, and the Company’s market position. Forward-looking statements are subject to certain risks and uncertainties that could cause the actual results to differ materially. Those risks and uncertainties include, but are not limited to, such factors as: the Company’s reliance on a small number of customers for a substantial portion of its revenues; market growth in China and other key countries; possible reduction in or volatility of customer orders or delays in shipments of products to customers; timing of customer drawdowns of vendor-managed inventory; potential governmental trade actions; possible disruptions in the supply chain or in demand for the Company’s products due to industry developments; the ability of the Company's vendors and subcontractors to supply or manufacture the Company's products in a timely manner; ability of the Company to meet customer demand; volatility in utilization of manufacturing operations and manufacturing costs; reductions in the Company’s rate of new design wins, and/or the rate at which design wins go into production, and the rate of customer acceptance of new product introductions; potential pricing pressure that may arise from changing supply or demand conditions in the industry; the impact of any previous or future acquisitions or divestitures of assets and related product lines; challenges involving integration of acquired businesses and utilization of acquired technology; the discontinuance or end of life of certain other products; market adoption, revenue growth and margins of acquired products; changes in demand for the Company's products; the impact of competitive products and pricing and alternative technological advances; the accuracy of estimates used to prepare the Company's financial statements and forecasts; the timely and successful development and market acceptance of new products and upgrades to existing products; the difficulty of predicting future cash needs; the nature of other investment opportunities available to the Company from time to time; the Company’s operating cash flow; changes in economic and industry projections; a decline in general conditions in the telecommunications equipment industry or the world economy generally; and the effects of seasonality. For further discussion of these risks and uncertainties, please refer to the documents the Company files with the SEC from time to time, including the Company's Annual Report on Form 10-K for the year ended December 31, 2017. All forward-looking statements are made as of the date of this press release, and the Company disclaims any duty to update such statements.
©2019 NeoPhotonics Corporation. All rights reserved. NeoPhotonics and the red dot logo are trademarks of NeoPhotonics Corporation. All other marks are the property of their respective owners.
| NeoPhotonics Corporation | ||||||||
| Condensed Consolidated Balance Sheets (Unaudited) | ||||||||
| (In thousands) | ||||||||
| As of | ||||||||
Dec. 31, | Dec. 31, | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 58,185 | $ | 78,906 | ||||
| Short-term investments | 7,481 | 12,311 | ||||||
| Restricted cash | 11,053 | 2,658 | ||||||
| Accounts receivable, net | 74,751 | 67,229 | ||||||
| Inventories | 52,159 | 67,301 | ||||||
| Assets held for sale | 2,971 | - | ||||||
| Prepaid expenses and other current assets | 26,605 | 36,235 | ||||||
| Total current assets | 233,205 | 264,640 | ||||||
| Property, plant and equipment, net | 100,090 | 127,565 | ||||||
| Purchased intangible assets, net | 3,018 | 4,294 | ||||||
| Goodwill | 1,115 | 1,115 | ||||||
| Other long-term assets | 3,148 | 5,339 | ||||||
| Total assets | $ | 340,576 | $ | 402,953 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 58,403 | $ | 69,017 | ||||
| Notes payable and short-term borrowing | 4,795 | 35,607 | ||||||
| Current portion of long-term debt | 2,897 | 6,005 | ||||||
| Accrued and other current liabilities | 50,288 | 43,242 | ||||||
| Total current liabilities | 116,383 | 153,871 | ||||||
| Long-term debt, net of current portion | 50,454 | 40,556 | ||||||
| Other noncurrent liabilities | 13,499 | 14,075 | ||||||
| Total liabilities | 180,336 | 208,502 | ||||||
| Stockholders' equity: | ||||||||
| Common stock | 116 | 111 | ||||||
| Additional paid-in capital | 564,722 | 545,953 | ||||||
| Accumulated other comprehensive income (loss) | (7,126 | ) | 398 | |||||
| Accumulated deficit | (397,472 | ) | (352,011 | ) | ||||
| Total stockholders' equity | 160,240 | 194,451 | ||||||
| Total liabilities and stockholders' equity | $ | 340,576 | $ | 402,953 | ||||
| NeoPhotonics Corporation | ||||||||||||||||||||
| Condensed Consolidated Statements of Operations (Unaudited) | ||||||||||||||||||||
| (In thousands, except percentages and per share data) | ||||||||||||||||||||
| Three Months Ended | Twelve Months Ended | |||||||||||||||||||
Dec. 31, | Sept. 30, | Dec. 31, | Dec. 31, | Dec. 31, | ||||||||||||||||
| Revenue | $ | 91,104 | $ | 81,748 | $ | 76,871 | $ | 322,540 | $ | 292,894 | ||||||||||
| Cost of goods sold (1) | 68,518 | 62,815 | 61,185 | 256,367 | 231,415 | |||||||||||||||
| Gross profit | 22,586 | 18,933 | 15,686 | 66,173 | 61,479 | |||||||||||||||
| Gross margin | 24.8 | % | 23.2 | % | 20.4 | % | 20.5 | % | 21.0 | % | ||||||||||
| Operating expenses: | ||||||||||||||||||||
| Research and development (1) | 13,510 | 13,177 | 13,875 | 53,818 | 58,287 | |||||||||||||||
| Sales and marketing (1) | 4,362 | 4,351 | 4,847 | 16,728 | 17,760 | |||||||||||||||
| General and administrative (1) | 7,344 | 8,142 | 7,661 | 30,403 | 34,453 | |||||||||||||||
| Amortization of purchased intangible assets | 118 | 118 | 117 | 475 | 472 | |||||||||||||||
| Asset sale related costs | 83 | 251 | (99 | ) | 427 | 130 | ||||||||||||||
| Restructuring charges | 1,349 | 1,133 | 384 | 3,135 | 3,934 | |||||||||||||||
| Litigation settlement | 2,195 | 450 | - | 2,645 | - | |||||||||||||||
| Loss (gain) on asset sale | 200 | - | (193 | ) | 200 | (2,193 | ) | |||||||||||||
| Total operating expenses | 29,161 | 27,622 | 26,592 | 107,831 | 112,843 | |||||||||||||||
| Loss from operations | (6,575 | ) | (8,689 | ) | (10,906 | ) | (41,658 | ) | (51,364 | ) | ||||||||||
| Interest income | 97 | 85 | 57 | 397 | 198 | |||||||||||||||
| Interest expense | (486 | ) | (540 | ) | (619 | ) | (2,493 | ) | (1,362 | ) | ||||||||||
| Other income (expense), net | (445 | ) | 1,310 | (93 | ) | 1,446 | 104 | |||||||||||||
| Total interest and other income (expense), net | (834 | ) | 855 | (655 | ) | (650 | ) | (1,060 | ) | |||||||||||
| Loss before income taxes | (7,409 | ) | (7,834 | ) | (11,561 | ) | (42,308 | ) | (52,424 | ) | ||||||||||
| Income tax (provision) benefit | 680 | (291 | ) | (2,722 | ) | (1,329 | ) | (909 | ) | |||||||||||
| Net loss | $ | (6,729 | ) | $ | (8,125 | ) | $ | (14,283 | ) | $ | (43,637 | ) | $ | (53,333 | ) | |||||
| Basic net loss per share | $ | (0.15 | ) | $ | (0.18 | ) | $ | (0.32 | ) | $ | (0.97 | ) | $ | (1.23 | ) | |||||
| Diluted net loss per share | $ | (0.15 | ) | $ | (0.18 | ) | $ | (0.32 | ) | $ | (0.97 | ) | $ | (1.23 | ) | |||||
| Weighted average shares used to compute basic net loss per share | 46,150 | 45,476 | 44,079 | 45,144 | 43,431 | |||||||||||||||
| Weighted average shares used to compute diluted net loss per share | 46,150 | 45,476 | 44,079 | 45,144 | 43,431 | |||||||||||||||
| (1) Includes stock-based compensation expense as follows for the periods presented: | ||||||||||||||||||||
| Cost of goods sold | $ | 764 | $ | 553 | $ | 287 | $ | 2,596 | $ | 1,098 | ||||||||||
| Research and development | 952 | 1,016 | 712 | 3,570 | 2,491 | |||||||||||||||
| Sales and marketing | 737 | 931 | 527 | 3,248 | 1,697 | |||||||||||||||
| General and administrative | 1,162 | 1,541 | 988 | 4,728 | 2,920 | |||||||||||||||
| Total stock-based compensation expense | $ | 3,615 | $ | 4,041 | $ | 2,514 | $ | 14,142 | $ | 8,206 | ||||||||||
| NeoPhotonics Corporation | ||||||||||||||||||||
| Reconciliation of Condensed Consolidated GAAP Financial Measures to Non-GAAP Financial Measures (Unaudited) | ||||||||||||||||||||
| (In thousands, except percentages and per share data) | ||||||||||||||||||||
| Three Months Ended | Twelve Months Ended | |||||||||||||||||||
Dec. 31, | Sept. 30, | Dec. 31, | Dec. 31, | Dec. 31, | ||||||||||||||||
| NON-GAAP GROSS PROFIT: | ||||||||||||||||||||
| GAAP gross profit | $ | 22,586 | $ | 18,933 | $ | 15,686 | $ | 66,173 | $ | 61,479 | ||||||||||
| Stock-based compensation expense | 764 | 553 | 287 | 2,596 | 1,098 | |||||||||||||||
| Amortization of purchased intangible assets | 184 | 185 | 203 | 756 | 870 | |||||||||||||||
| Depreciation of acquisition-related fixed asset step-up | (75 | ) | (71 | ) | (68 | ) | (288 | ) | (270 | ) | ||||||||||
| End-of-life related inventory write-down | 2,565 | - | - | 2,565 | 1,975 | |||||||||||||||
| Restructuring charges | - | 22 | 248 | 168 | 812 | |||||||||||||||
| Non-GAAP gross profit | $ | 26,024 | $ | 19,622 | $ | 16,356 | $ | 71,970 | $ | 65,964 | ||||||||||
| Non-GAAP gross margin as a % of revenue | 28.6 | % | 24.0 | % | 21.3 | % | 22.3 | % | 22.5 | % | ||||||||||
| NON-GAAP TOTAL OPERATING EXPENSES: | ||||||||||||||||||||
| GAAP total operating expenses | $ | 29,161 | $ | 27,622 | $ | 26,592 | $ | 107,831 | $ | 112,843 | ||||||||||
| Stock-based compensation expense | (2,851 | ) | (3,488 | ) | (2,227 | ) | (11,546 | ) | (7,108 | ) | ||||||||||
| Amortization of purchased intangible assets | (118 | ) | (118 | ) | (117 | ) | (475 | ) | (472 | ) | ||||||||||
| Depreciation of acquisition-related fixed asset step-up | (66 | ) | (65 | ) | (69 | ) | (266 | ) | (285 | ) | ||||||||||
| Asset sale related costs | (83 | ) | (251 | ) | 99 | (427 | ) | (130 | ) | |||||||||||
| Restructuring charges | (1,349 | ) | (1,133 | ) | (384 | ) | (3,135 | ) | (3,934 | ) | ||||||||||
| Litigation settlement | (2,195 | ) | (450 | ) | - | (2,645 | ) | 64 | ||||||||||||
| Loss (gain) on asset sale | (200 | ) | - | 193 | (200 | ) | 2,193 | |||||||||||||
| Non-GAAP total operating expenses | $ | 22,299 | $ | 22,117 | $ | 24,087 | $ | 89,137 | $ | 103,171 | ||||||||||
| Non-GAAP total operating expenses as a % of revenue | 24.5 | % | 27.1 | % | 31.3 | % | 27.6 | % | 35.2 | % | ||||||||||
| NON-GAAP OPERATING INCOME (LOSS): | ||||||||||||||||||||
| GAAP loss from operations | $ | (6,575 | ) | $ | (8,689 | ) | $ | (10,906 | ) | $ | (41,658 | ) | $ | (51,364 | ) | |||||
| Stock-based compensation expense | 3,615 | 4,041 | 2,514 | 14,142 | 8,206 | |||||||||||||||
| Amortization of purchased intangible assets | 302 | 303 | 320 | 1,231 | 1,342 | |||||||||||||||
| Depreciation of acquisition-related fixed asset step-up | (9 | ) | (6 | ) | 1 | (22 | ) | 15 | ||||||||||||
| Asset sale related costs | 83 | 251 | (99 | ) | 427 | 130 | ||||||||||||||
| End-of-life related inventory write-down | 2,565 | - | - | 2,565 | 1,975 | |||||||||||||||
| Restructuring charges | 1,349 | 1,155 | 632 | 3,303 | 4,746 | |||||||||||||||
| Litigation settlement | 2,195 | 450 | - | 2,645 | (64 | ) | ||||||||||||||
| Loss (gain) on asset sale | 200 | - | (193 | ) | 200 | (2,193 | ) | |||||||||||||
| Non-GAAP income (loss) from operations | $ | 3,725 | $ | (2,495 | ) | $ | (7,731 | ) | $ | (17,167 | ) | $ | (37,207 | ) | ||||||
| Non-GAAP operating margin as a % of revenue | 4.1 | % | (3.1 | )% | (10.1 | )% | (5.3 | )% | (12.7 | )% | ||||||||||
| NeoPhotonics Corporation | ||||||||||||||||||||
| Reconciliation of Condensed Consolidated GAAP Financial Measures to Non-GAAP Financial Measures (Unaudited) (Continued) | ||||||||||||||||||||
| (In thousands, except percentages and per share data) | ||||||||||||||||||||
| Three Months Ended | Twelve Months Ended | |||||||||||||||||||
Dec. 31, | Sept. 30, | Dec. 31, | Dec. 31, | Dec. 31, | ||||||||||||||||
| NON-GAAP NET INCOME (LOSS): | ||||||||||||||||||||
| GAAP net loss | $ | (6,729 | ) | $ | (8,125 | ) | $ | (14,283 | ) | $ | (43,637 | ) | $ | (53,333 | ) | |||||
| Stock-based compensation expense | 3,615 | 4,041 | 2,514 | 14,142 | 8,206 | |||||||||||||||
| Amortization of purchased intangible assets | 302 | 303 | 320 | 1,231 | 1,342 | |||||||||||||||
| Depreciation of acquisition-related fixed asset step-up | (9 | ) | (6 | ) | 1 | (22 | ) | 15 | ||||||||||||
| Asset sale related costs | 83 | 251 | (99 | ) | 427 | 130 | ||||||||||||||
| End-of-life related inventory write-down | 2,565 | - | - | 2,565 | 1,975 | |||||||||||||||
| Restructuring charges | 1,349 | 1,155 | 632 | 3,303 | 4,746 | |||||||||||||||
| Litigation settlement | 2,195 | 450 | - | 2,645 | (64 | ) | ||||||||||||||
| Loss (gain) on asset sale | 200 | - | (193 | ) | 200 | (2,193 | ) | |||||||||||||
| Income tax effect of Non-GAAP adjustments | (1,153 | ) | (138 | ) | (637 | ) | (1,375 | ) | (754 | ) | ||||||||||
| Non-GAAP net income (loss) | $ | 2,418 | $ | (2,069 | ) | $ | (11,745 | ) | $ | (20,521 | ) | $ | (39,930 | ) | ||||||
| Non-GAAP net income (loss) as a % of revenue | 2.7 | % | (2.5 | )% | (15.3 | )% | (6.4 | )% | (13.6 | )% | ||||||||||
| ADJUSTED EBITDA: | ||||||||||||||||||||
| GAAP net loss | $ | (6,729 | ) | $ | (8,125 | ) | $ | (14,283 | ) | $ | (43,637 | ) | $ | (53,333 | ) | |||||
| Stock-based compensation expense | 3,615 | 4,041 | 2,514 | 14,142 | 8,206 | |||||||||||||||
| Amortization of purchased intangible assets | 302 | 303 | 320 | 1,231 | 1,342 | |||||||||||||||
| Depreciation of acquisition-related fixed asset step-up | (9 | ) | (6 | ) | 1 | (22 | ) | 15 | ||||||||||||
| Asset sale related costs | 83 | 251 | (99 | ) | 427 | 130 | ||||||||||||||
| End-of-life related inventory write-down | 2,565 | - | - | 2,565 | 1,975 | |||||||||||||||
| Restructuring charges | 1,349 | 1,155 | 632 | 3,303 | 4,746 | |||||||||||||||
| Litigation settlement | 2,195 | 450 | - | 2,645 | (64 | ) | ||||||||||||||
| Loss (gain) on asset sale | 200 | - | (193 | ) | 200 | (2,193 | ) | |||||||||||||
| Interest expense, net | 389 | 455 | 562 | 2,096 | 1,164 | |||||||||||||||
| Provision (benefit) for income taxes | (680 | ) | 291 | 2,722 | 1,329 | 909 | ||||||||||||||
| Depreciation expense | 7,260 | 7,343 | 7,402 | 29,896 | 27,010 | |||||||||||||||
| Adjusted EBITDA | $ | 10,540 | $ | 6,158 | $ | (422 | ) | $ | 14,175 | $ | (10,093 | ) | ||||||||
| Adjusted EBITDA as a % of revenue | 11.6 | % | 7.5 | % | (0.5 | )% | 4.4 | % | (3.4 | )% | ||||||||||
| BASIC AND DILUTED NET INCOME (LOSS) PER SHARE: | ||||||||||||||||||||
| GAAP basic net loss per share | $ | (0.15 | ) | $ | (0.18 | ) | $ | (0.32 | ) | $ | (0.97 | ) | $ | (1.23 | ) | |||||
| GAAP diluted net loss per share | $ | (0.15 | ) | $ | (0.18 | ) | $ | (0.32 | ) | $ | (0.97 | ) | $ | (1.23 | ) | |||||
| Non-GAAP basic net income (loss) per share | $ | 0.05 | $ | (0.05 | ) | $ | (0.27 | ) | $ | (0.45 | ) | $ | (0.92 | ) | ||||||
| Non-GAAP diluted net income (loss) per share | $ | 0.05 | $ | (0.05 | ) | $ | (0.27 | ) | $ | (0.45 | ) | $ | (0.92 | ) | ||||||
| SHARES USED TO COMPUTE GAAP AND NON-GAAP BASIC NET INCOME (LOSS) PER SHARE | 46,150 | 45,476 | 44,079 | 45,144 | 43,431 | |||||||||||||||
| SHARES USED TO COMPUTE GAAP DILUTED NET LOSS PER SHARE | 46,150 | 45,476 | 44,079 | 45,144 | 43,431 | |||||||||||||||
| SHARES USED TO COMPUTE NON-GAAP DILUTED NET INCOME (LOSS) PER SHARE | 49,334 | 45,476 | 44,079 | 45,144 | 43,431 | |||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20190228005895/en/
Contacts:
Beth Eby, Chief Financial Officer
+1-408-895-6086
ir@neophotonics.com
